Navana Pharmaceuticals PLC (DSE:NAVANAPHAR)
Bangladesh · Delayed Price · Currency is BDT 70.90
+1.30 (1.87%)
At close: May 24, 2026
Navana Pharmaceuticals Market Cap
Navana Pharmaceuticals has a market cap or net worth of 7.62 billion as of May 26, 2026. Its market cap has increased by 27.98% in one year.
Market Cap
7.62B
Enterprise Value
11.51B
Revenue
10.07B
Ranking
n/a
PE Ratio
12.56
Stock Price
70.90
Market Cap Chart
Since October 18, 2022, Navana Pharmaceuticals's market cap has increased from 2.84B to 7.62B, an increase of 168.56%. That is a compound annual growth rate of 31.58%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 24, 2026 | 7.62B | 36.61% |
| Dec 30, 2025 | 5.57B | 6.79% |
| Dec 30, 2024 | 5.22B | -42.42% |
| Dec 28, 2023 | 9.07B | 7.79% |
| Dec 29, 2022 | 8.41B | 196.59% |
| Oct 18, 2022 | 2.84B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Beacon Pharmaceuticals | 23.49B |
| The ACME Laboratories | 16.19B |
| Asiatic Laboratories | 15.97B |
| The IBN SINA Pharmaceutical Industry | 9.86B |
| Orion Pharma | 6.11B |
| Techno Drugs | 5.91B |
| Ambee Pharmaceuticals | 1.87B |
| Pharma Aids | 1.81B |